Multimodality Therapy for Locally Advanced Cervical Carcinoma: State of the Art and Future Directions We reviewed the current evidence on the clinical management of these relatively rare ovarian ...

A 54-year-old woman with ovarian cancer underwent TAH/BSO. Pathology showed stromal cell carcinoma, stage I. Her CA125 after surgery is 85; before surgery, it was 200. Is adjuvant chemotherapy ...

Researchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer: a subset of progenitor cells that reside in fallopian tube supportive tissue, or stroma.

High-risk MSCs (yellow) are more abundant in fallopian tubes from patients with STIC lesions (bottom) compared to those without these lesions (top). Researchers at the University of Pittsburgh have ...

This study is a collaborative effort led by Dr. Hua Zhang, Dr. Yan Zhang, and Dr. Yuwen Ke from the Department of Zoology and Animal Physiology at the College of Biological Sciences, China ...

Ovarian cancer often goes undetected for a long time. In seven out of 10 patients, the tumor has already formed secondary ...

Most ovarian cancers are treated the same way regardless of stage: surgery followed by chemotherapy. Stromal tumors are treated with surgery followed by chemotherapy or hormone therapy. In most cases, ...

The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...

SAN JOSE, Calif., Feb. 18, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer today ...